Black Drop Biodrucker
Develops modular 3D bioprinters and specialized bioinks for creating living tissues and organ-like structures, enabling researchers to advance medical treatments without the complexity of traditional systems.
- CEO / Founder
- Roger Henriques
- Team Size
- 11-50
- Stage
- Active
- Key Investors
- Bundesministerium für Bildung und Forschung (BMBF)
Technology & Products
Key Products
Regenate Bio Printer, Handheld Printing, SuperFill Bioinks, tissue models, and a range of customized 3D bioprinting hardware and software solutions.
Technological Advantage
Proprietary bioink formulations (e.g., Blue Drop, CureDrop) achieve high shape fidelity and cell viability, protected by 3 patents; modular printer design allows customization for diverse research needs, creating switching costs.
Differentiation
Value Proposition
Reduces bioprinting complexity and cost by 30-50% compared to traditional systems, offering customizable hardware and bioinks that accelerate tissue engineering research from months to weeks.
How They Differentiate
Offers modular bioprinters with up to 7 printheads vs. Cellink's standard 2-3, at 30% lower cost for entry-level systems; proprietary bioinks provide 20% higher cell viability in published studies compared to generic hydrogels.
Market & Competition
Target Customers
Medical researchers, academic institutions, pharmaceutical companies
Industry Verticals
Medical Research; Pharmaceuticals; Biotechnology
Competitors
CELLINK, Organovo, Brinter
Growth & Milestones
Growth Metrics
Team expanded with 2 new employees in 2025; involved in 6 research projects with 20+ partners as of 2024.
Major Milestones
Founded in 2017; Launched SuperFill Robo bioprinter in 2019; Introduced Black Drop Regenate modular bioprinter; Published 10+ research papers; Secured 3 patents
Notable Customers
GELITA, NMI Natural and Medical Sciences Institute, TU Darmstadt, cellQART